Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.
Randomized, Single Blind, Prospective Clinical Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Terminated
Difficulties in recruitment
Other terminated trials from Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Leiomyoma · Sep 2021
- Leiomyoma, Uterine · Dec 2019
- Huntington Disease · Phase PHASE1 · May 2016
- Pneumococcal Meningitis · Phase PHASE4 · Dec 2015
- Blood Loss · Phase PHASE3 · May 2015
See all terminations from Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Other Polycystic Ovary Syndrome trials with similar outcome
A PHASE4 clinical study on Polycystic Ovary Syndrome, this trial is terminated or withdrawn. The trial is conducted by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Mar 2019 — Jan 2021 [monthly]
Terminated PHASE4
Status: Not Yet Recruiting → Terminated
-
Jun 2018 — Mar 2019 [monthly]
Not Yet Recruiting PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Programa de Reproducción Asistida F. Puigvert - HSCSP
For direct contact, visit the study record on ClinicalTrials.gov .